CAS: 2244904-70-7
BAY-293
CAS:2244904-70-7
BAY-293 is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction (IC50: 21 nM).
Formula:
C25H28N4O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
448.58
Ref: TM-T5418
| 1mg | 52.00 € | |
| 5mg | 109.00 € | |
| 10mg | 183.00 € | |
| 25mg | 368.00 € | |
| 50mg | 547.00 € | |
| 100mg | 786.00 € | |
| 1ml*10 (DMSO) | 121.00 € |
Estimated delivery in United States, on Monday 6 May 2024
(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine
CAS:2244904-70-7
Purity:
98.0%
Color and Shape:
Liquid
Molecular weight:
448.5899963378906
Ref: 10-F546324
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
![6,7-Dimethoxy-2-methyl-N-[(1R)-1-[4-[2-[(methylamino)methyl]phenyl]-2-thienyl]ethyl]-4-quinazolinamine](https://static.cymitquimica.com/products/TR/thumb/D224490.jpg)
6,7-Dimethoxy-2-methyl-N-[(1R)-1-[4-[2-[(methylamino)methyl]phenyl]-2-thienyl]ethyl]-4-quinazolinamine
CAS:2244904-70-7
Formula:
C25H28N4O2S
Molecular weight:
448.58
Ref: TR-D224490
| 25mg | 15,221.00 € |
Estimated delivery in United States, on Tuesday 11 Jun 2024
BAY 293
CAS:2244904-70-7
BAY 293 is a tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR) …
Formula:
C25H28N4O2S
Purity:
Min. 95%
Molecular weight:
448.59 g/mol
Ref: 3D-UPD90470
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Jun 2024
![(R)-(6,7-Dimethoxy-2-methyl-quinazolin-4-yl)-[1-[4-(2-methylaminomethyl-phenyl)-thiophen-2-yl]-ethyl]-amine](https://static.cymitquimica.com/products/AN/thumb/AG01FW1F.jpg)
(R)-(6,7-Dimethoxy-2-methyl-quinazolin-4-yl)-[1-[4-(2-methylaminomethyl-phenyl)-thiophen-2-yl]-ethyl]-amine
CAS:2244904-70-7
Formula:
C25H28N4O2S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
448.5804
Ref: AN-AG01FW1F
| 100mg | Discontinued | |
| 250mg | Discontinued |
